Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices 39127 

appropriate Indian Tribes or Native 

Hawaiian organizations, and has 

determined that there is no cultural 

affiliation between the human remains 

and any present-day Indian Tribes or 

Native Hawaiian organizations. 

Representatives of any Indian Tribe or 

Native Hawaiian organization not 

identified in this notice that wish to 

request transfer of control of these 

human remains should submit a written 

request to the NYU College of Dentistry. 

If no additional requestors come 

forward, transfer of control of the 

human remains to the Indian Tribes or 

Native Hawaiian organizations stated in 

this notice may proceed. 

DATES: Representatives of any Indian 

Tribe or Native Hawaiian organization 

not identified in this notice that wish to 

request transfer of control of these 

human remains should submit a written 

request with information in support of 

the request to the NYU College of 

Dentistry at the address in this notice by 

September 7, 2018. 

ADDRESSES: Dr. Louis Terracio, NYU 

College of Dentistry, 345 East 24th 

Street, New York, NY 10010, telephone 

(212) 998–9717, email louis.terracio@

nyu.edu. 

SUPPLEMENTARY INFORMATION: Notice is 

here given in accordance with the 

Native American Graves Protection and 

Repatriation Act (NAGPRA), 25 U.S.C. 

3003, of the completion of an inventory 

of human remains under the control of 

the NYU College of Dentistry, New York 

City, NY. The human remains were 

removed from Shinnecock Hills, Suffolk 

County, Long Island, NY. 

This notice is published as part of the 

National Park Service’s administrative 

responsibilities under NAGPRA, 25 

U.S.C. 3003(d)(3) and 43 CFR 10.11(d). 

The determinations in this notice are 

the sole responsibility of the museum, 

institution, or Federal agency that has 

control of the Native American human 

remains. The National Park Service is 

not responsible for the determinations 

in this notice. 

Consultation 

A detailed assessment of the human 

remains was made by the NYU College 

of Dentistry professional staff in 

consultation with representatives of the 

Delaware Nation, Oklahoma; Delaware 

Tribe of Indians; Shinnecock Indian 

Nation; and Stockbridge Munsee 

Community, Wisconsin. 

History and Description of the Remains 

At an unknown date, human remains 

representing, at minimum, one 

individual were removed from an 

unknown site in Shinnecock Hills, 

Suffolk County, NY. In 1926, the town 

of Southampton donated the human 

remains, which consist of the cranial 

fragments of one adult, to the Museum 

of the American Indian, Heye 

Foundation. They were accessioned into 

the collection of the Department of 

Physical Anthropology of the Museum 

of the American Indian, Heye 

Foundation that same year. In 1956, the 

human remains were transferred to Dr. 

Theodore Kazamiroff, NYU College of 

Dentistry. No known individuals were 

identified. No associated funerary 

objects are present. The age of the 

human remains cannot be determined 

from the available information. Forensic 

examination revealed diagnostic 

features of an individual with Native 

American ancestry. Without any 

information about the site or age of the 

remains, no identifiable earlier group 

can be determined. 

Shinnecock Hills, which lies near the 

northeastern end of Long Island, is not 

included in any treaties, Acts of 

Congress, or Executive Orders that 

establish aboriginal land. The area is, 

however, within territory that was long 

recognized by the tribe, the town of 

Southampton, and the state of New York 

as Shinnecock land. In 1703, the 

Shinnecock and town of Southampton 

reached an agreement in which the 

Shinnecock held a 1,000 year lease of 

approximately 3,500 acres, including 

Shinnecock Hills. The area was 

subsequently referred to as the 

Shinnecock Reservation in various state 

and local documents. The Shinnecock 

renegotiated their lease in 1859 and 

relinquished the lands at Shinnecock 

Hills in exchange for fee title to the land 

at Shinnecock Neck. The current 

Shinnecock Reservation, which no 

longer includes Shinnecock Hills, was 

placed into trust after the tribe was 

federally recognized in 2010. The 

Department of Interior proposed finding 

on the Shinnecock petition for federal 

recognition identifies Shinnecock Hills 

as part of the pre-1859 Shinnecock 

Reservation. 

Determinations Made by the NYU 

College of Dentistry 

Officials of the NYU College of 

Dentistry have determined that: 

• Pursuant to 25 U.S.C. 3001(9), the 

human remains described in this notice 

are Native American based on 

diagnostic cranial features observed 

during forensic examination. 

• Pursuant to 25 U.S.C. 3001(9), the 

human remains described in this notice 

represent the physical remains of one 

individual of Native American ancestry. 

• Pursuant to 25 U.S.C. 3001(2), a 

relationship of shared group identity 

cannot be reasonably traced between the 

Native American human remains and 

any present-day Indian Tribe. 

• Authoritative governmental 

documents, including the Shinnecock 

Indian Nation’s federal recognition 

decision, state agreements, and local 

property records indicate that the land 

from which the Native American human 

remains were removed is the aboriginal 

land of the Shinnecock Indian Nation. 

• Pursuant to 43 CFR 10.11(c)(1), the 

disposition of the human remains may 

be to the Shinnecock Indian Nation. 

Additional Requestors and Disposition 

Representatives of any Indian Tribe or 

Native Hawaiian organization not 

identified in this notice that wish to 

request transfer of control of these 

human remains should submit a written 

request with information in support of 

the request to Dr. Louis Terracio, NYU 

College of Dentistry, 345 East 24th 

Street, New York, NY 10010, telephone 

(212) 998–9717, email louis.terracio@

nyu.edu, by September 7, 2018. After 

that date, if no additional requestors 

have come forward, transfer of control 

of the human remains to the Shinnecock 

Indian Nation may proceed. 

The NYU College of Dentistry is 

responsible for notifying the Shinnecock 

Indian Nation that this notice has been 

published. 

Dated: June 29, 2018. 

Melanie O’Brien, 

Manager, National NAGPRA Program. 

[FR Doc. 2018–16920 Filed 8–7–18; 8:45 am] 

BILLING CODE 4312–52–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Clinical Supplies 

Management Holdings, Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before September 7, 2018. Such 

persons may also file a written request 

for a hearing on the application on or 

before September 7, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 


sradovich on DSK3GMQ082PROD with NOTICES
39128 Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on June 

29, 2018, Clinical Supplies Management 

Holdings, Inc., 342 42nd Street South, 

Fargo, North Dakota 58103–1132 

applied to be registered as an importer 

of the following basic classes of 

controlled substances: 

Controlled substance Drug 

code Schedule 

Marihuana ..................... 7360 I 

Tetrahydrocannabinols 7370 I 

The company plans to import the 

listed controlled substances to 

manufacture bulk controlled substances 

for use in clinical trials only. 

Dated: July 31, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16939 Filed 8–7–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: AndersonBrecon Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before September 7, 2018. Such 

persons may also file a written request 

for a hearing on the application on or 

before September 7, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

Comments and requests for hearings on 

applications to import narcotic raw 

material are not appropriate. 72 FR 

3417, (January 25, 2007) 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on May 2, 

2018, AndersonBrecon Inc., 5775 

Logistics Parkway, Rockford, Illinois 

61109 applied to be registered as an 

importer of the following basic class of 

controlled substance: 

Controlled substance Drug 

code Schedule 

Tetrahydrocannabinols ......................................................................................................................................... 7370 I 

The company plans to import the 

listed controlled substances for clinical 

trial only. Approval of permit 

applications will occur only when the 

registrant’s business activity is 

consistent with what is authorized 

under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of FDA approved or nonapproved finished dosage forms for 

commercial sale. 

Dated: July 31, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16937 Filed 8–7–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Registration 

ACTION: Notice of registration. 

SUMMARY: Registrants listed below have 

applied for and been granted 

registration by-the Drug Enforcement 

Administration (DEA) as importers of 

various classes of schedule I or II 

controlled substances. 

SUPPLEMENTARY INFORMATION: The 

companies listed below applied to be 

registered as importers of various basic 

classes of controlled substances. 

Information on previously published 

notices is listed in the table below. No 

comments or objections were submitted 

and no requests for hearing were 

submitted for these notices. 


sradovich on DSK3GMQ082PROD with NOTICES